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Abstract
Cigarette smoke exposure markedly compromises the ability of the immune system to protect against invading pathogens
and tumorigenesis. Nicotine is a psychoactive component of tobacco products that acts as does the natural
neurotransmitter, acetylcholine, on nicotinic receptors (nAChRs). Here we demonstrate that natural killer (NK) cells strongly
express nAChR b2. Nicotine exposure impairs the ability of NK cells to kill target cells and release cytokines, a process that is
largely abrogated by nAChR b2 deficiency. Further, nicotinic suppression of NF-kB-induced transcriptional activity in NK
cells is dependent on nAChR b2. This nAChR subtype also plays a large role in the NK cell-mediated control of melanoma
lung metastasis, in a murine lung metastasis model exposed to nicotine. Our findings suggest nAChR b2 as a prominent
pathway for nicotine induced impairment of NK cell functions which contributes to the occurrence of smoking-related
pathologies.
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Introduction
Smoking related disorders such as infection and tumorigenesis
have been linked to the compromised functions of the immune
system in smokers [1,2]. Among the multiple immune-modifying
components of tobacco smoke, nicotine has been shown to have a
profound impact on a number of nicotinic acetylcholine receptor
(nAChR)-bearing leukocytes from both innate and adaptive
immune systems. Expression of nAChR a7 on macrophages and
monocytes, and its ability to inhibit the immune response during
systemic inflammation and in organ-specific diseases have been
relatively well described [3,4,5,6,7,8]. Results suggest that nicotine
regulates the intensity of endotoxemia and sepsis [3,4,5], and
attenuates -specific autoimmune responses in an nAChR a7-
dependent manner [6,7,8]. On the other hand, it has recently been
demonstrated that other nAChR subtypes may play a role in
nicotine’s anti-inflammatory effects [3,4,5,6,7,8]. In this context,
the expression profile of additional nAChRs on leukocytes and
their role in disease are relatively less explored.
NK cells are large, granular lymphocytes that operate through
cytolytic activity and cytokine secretion. These two functions
empower NK cells in innate host defense against certain microbial
agents and cells undergoing malignant transformation. Several
studies have shown that NK cell numbers and activities are
decreased in smokers compared with non-smokers [1,2]. Exposure
to cigarette smoke attenuates the cytotoxic activity and cytokine
production of NK cells in humans and mice [9,10,11], thereby
linking NK cell defects to increased infection and cancer. Smoking
has been particularly associated with the highly malignant small
cell lung cancer. Even after surgical removal at an early stage,
nearly half of patients die from a secondary tumor metastasis. It is
postulated that this is due in part to defective NK cell-mediated
immune surveillance because aberrant NK cell function in
smokers increases the re-emergence of cervical cancer metastasis
[12].
Here, we comprehensively examined the cellular and molecular
effects of nicotine as one of the components of cigarette smoke on
NK cells. We profiled nAChR expression on NK cells and
identified nAChR b2 as a key determinant for nicotine-mediated
impairment of NK cell functions. Further, we demonstrate that
nicotinic inhibition of NK cell functions via nAChR b2
significantly increases melanoma metastasis in a xenogeneic
model.
Materials and Methods
Animals
Female C57BL/6 mice (6–8 wk old), RAG2–/–, RAG2–/–cc
–/–,
all on a C57BL/6 background, were purchased from Taconic
Farms. a7 and b2 KO mice [13], also crossed to C57BL/6
background, were kindly provided by Dr Allan C. Collins. Mice
were maintained under pathogen-free conditions. The Animal
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Research Ethics Board of Tianjin Medical University and St.
Joseph’s Hospital and Medical Center approved all experiments
described in this study.
mRNA Purification and Reverse-transcription PCR
mRNA was purified from fresh acutely-isolated cells (,1.56106
cells per sample) by using the mMACS mRNA isolation kit
(Miltenyi Biotec), as per the supplied protocol. Reverse transcrip-
tion was performed with the SuperScript III First Strand cDNA
Synthesis kit (Invitrogen, USA) by following the supplied protocol.
Oligo-dT sequences were used to prime the reverse transcriptase.
PCR was then performed following established protocols, using a
variety of primers that are specific to each target mRNA (Table 1).
Primer pairs were designed with the use of PubMed’s ‘‘Primer-
blast’’ tool (http://www.ncbi.nlm.nih.gov/tools/primer-blast/).
For each pair, forward and reverse primers were specific to
different exons, so that potential DNA contamination could be
ruled out. PCR was performed using the RedTaq PCR kit (Sigma,
USA), according to the supplied protocol. Primers were always
tested with total brain cDNA (positive control), and the optimal
annealing temperature (Tm) was determined empirically (with the
use of a Temperature gradient thermocycler), while maintaining
high stringency conditions. A negative control (no cDNA
template), was included in every set of reactions. PCR products
for each primer pair from positive controls were sequenced in
order to ensure the accuracy of our results.
Overall nAChR Expression Assessed by Radioligand
Saturation Binding
Epibatidine, which is selective for b2- and b4-containing
nAChRs (which can assemble with a4, a5, a6 and b3 subunits),
was used to assess the amount of b2-containing nAChRs, as done
previously [14,15]. In order to maximize assay sensitivity, we used
high specific activity [125I]epibatidine (I-Epi; 2200 Ci mmol21; PE
Life Sciences, Waltham, MA). To this end, purified NK cells were
used immediately after isolation. Cells were resuspended in
isotonic binding buffer (mM: NaCl, 144; KCl, 2; CaCl2, 2;
MgSO4, 1; HEPES 20; pH=7.5), supplemented with bovine
serum albumin (0.1% (w/v)). Incubations were performed at 22 uC
for 2 h in 96-well plates. Samples were incubated with a range of
eight concentrations (6.25 – 800 pM) of I-Epi in a total volume of
30 ml of supplemented isotonic binding buffer. Total (no peptide
added) and non-specific binding (defined using 100 mM carba-
mycholine) were measured at each concentration, in triplicate. To
differentiate b2- from b4-containing nAChRs, 10 nM A85380 was
added in conjuncton with 200 pM I-Epi [14]. Binding reactions
were terminated and washed by filtration using a 96-place
manifold. Particulate fractions were collected onto single layers
of Inotech 0.75 mm retention glass fiber filters soaked in 0.5 %
polyethyleneimine. Bound radioligand were quantified using a
Microbeta plate counter (PerkinElmer Life Sciences, Wellesley,
MA).
Nicotine Treatment in vivo and in vitro
For in vivo delivery, a 100 mg/ml solution containing (-
)nicotine bitartrate (Sigma, St. Louis, MO, USA) in phosphate-
buffered saline (PBS) or a solution of PBS alone was freshly
prepared 24 h before pump implantation and loaded into AlzetH
osmotic minipumps (model 2006, Durect Corporation, Cupertino,
CA, USA). The pumps were implanted subcutaneously on the
right side of the back of the mouse and continuously delivered
either PBS or nicotine salt at 3.6 ml/d for 6 weeks, and then the
pumps were removed. This equated to delivery of 0.39 mg of
nicotine free base per mouse per day. For an ,30 gm mouse,
which is at the upper end of weight for animals used in the study,
this equates to,13 mg of nicotine free base/kg/d or,0.54 mg of
nicotine free base/kg/hr. Plasma nicotine levels in mice are
,100–200 ng/ml (,0.6–1.2 mM) after infusion of ,2–4 mg/kg/
hr of drug and ,45 ng/ml (,280 nM) after infusion at ,0.5 mg/
kg/hr. For comparison, human smokers have peak plasma
nicotine levels of 10–50 ng/ml (,60–310 nM). Thus, nicotine
levels in plasma (extrapolated to be ,49 ng/ml or ,300 nM) of
mice used in the studies are comparable to those in the plasma of
human smokers. Some control mice received PBS via direct
injections rather than through minipumps, but either delivery
method produced similar results. For the in vitro experiments,
0.1–100 mM/ml of nicotine was added to the cell cultures.
B16 Melanoma Cell Line and Tumor Challenge
B16-F10-luc2 (B16) is a luciferase-expressing cell line from
mouse melanoma (Caliper Life Sciences, Alameda, CA, USA).
Mice of the indicated genotypes were challenged i.v. with B16 cells
Table 1. Primers used to detect nAChR subunits.
nAChR NCBI Forward Primer Reverse Primer Product Tm
Subunit Template Sequence Sequence Size (bp) (6C)
a3 NM_145129.2 gccaacctcacaagaagctc atgtggggtttagcagcaac 680 58
a4 NM_015730.5 cagtagccaatatctcagat gtagaacagtggcagtcgg 577 55
a5 NM_176844.3 gggttcgtcctgtggaacacctga ggtcctgtaggattatatcg 431 58
a6 NM_021369.2 tgttccagcagataacatctg tgaattgaacactctcgatg 987 55
a7 NM_007390.3 cgtgggcctctcagtggtcg ggccatgaggcacaagcggt 514 58
a9 NM_001081104.1 ctatttccccttcgacag ttttgtcagtgcttcatagc 798 55
b2 NM_009602.3 ctccaactctatggcgctgct cgtcggcctggcagtgcgat 623 58
b3 NM_173212.3 acggagagtaagggaaccgt accagcagccctcagttcta 364 58
b4 NM_148944.4 tctctgttcgctctgcttca acacagtggtgacgatggaa 913 58
Primer pairs were designed with the use of PubMed’s ‘‘Primer-blast’’ tool (http://www.ncbi.nlm.nih.gov/tools/primer-blast/). For each pair, forward and reverse primers
were specific to different exons, so that potential DNA contamination could be ruled out. The optimal annealing temperature (Tm) was determined empirically with the
use of a temperature gradient thermocycler, while maintaining high stringency conditions. PCR products for each primer pair were sequenced in order to ensure the
accuracy of our results.
doi:10.1371/journal.pone.0057495.t001
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in 0.2 ml of PBS via the tail vein. Cell numbers used and times of
sacrifice are referred to previously established protocols [9,15,16]
and specified in the results section. Animals were anesthetized and
euthanized via exsanguinations through abdominal vein puncture.
Lungs were removed and placed in PBS. Tumor nodules were
counted using a dissecting microscope by a researcher blinded to
the treatment groups. In some cases, lungs were immersed in a
67% ethanol, 9% formaldehyde, and 4% glacial acetic acid
solution and the number of tumor foci was enumerated 24–48 h
later.
Isolation of Lung Mononuclear Cells
Lung mononuclear cells were isolated as described previously
[17]. Briefly, lungs were perfused with prewarmed HBSS from the
right ventricle. Cell suspensions from excised organs were
generated by collagenase digestion and followed by mechanical
mincing. Cell debris were removed by passing through nylon
mesh. Cells were washed and resuspended in HBSS. Nonpar-
enchymal cells were isolated by density-gradient centrifugation
with Lympholyte-M (Cedarlane Laboratories).
NK Cell Cytotoxicity Assays
NK cell cytotoxicity was assessed by the chromium release assay
using 51Cr-labeled YAC-1 murine lymphoma cell line [18] or B16
tumor cells. Freshly purified NK cells were incubated with 51Cr-
labeled target cells (5 6 103) at various effector cell/target cell
ratios. After 4 h of incubation, the supernatants were harvested
and 51Cr-release was measured with a c-counter (PerkinElmer,
Waltham, MA). The percentage of specific lysis was calculated
according to the following formula: (experimental release –
spontaneous release) / (maximum release - spontaneous release)
6 100. Cytotoxicity assays were done in triplicate [18].
NK Cell Proliferation Assays
NK cells were isolated from the spleen of mice that were treated
with nicotine or PBS. Cells were suspended in culture medium
containing Dulbecco’s modification of Eagle’s medium (Gibco,
Paisley, UK) supplemented with 1% (v/v) minimum essential
medium (Gibco), 2 mM glutamine (Flow Laboratory, Irvine, CA,
USA), 50 IU/ml penicillin, 50 mg/ml streptomycin, and with
10% (v/v) FCS (all from Gibco). 46105 cells in 200 ml of culture
medium were placed in each well of 96-well, round-bottom
microtiter plates (Nunc, Copenhagen, Denmark). For the in vitro
nicotine exposure experiments, nicotine (0.1–100 mM) was added
to the culture medium in addition to LPS (10 mg/ml). After 3 days
of incubation, the cells were pulsed for 18 h with 10 ml aliquots
containing 1 mCi of 3H-methylthymidine (specific activity of
42 Ci/mmol; MP Biomedicals, Irvine, CA, USA) per well. Cells
were harvested onto glass fiber filters and thymidine incorporation
proportional to the degree of cell proliferation was then measured.
The results are expressed as counts per minute (cpm).
FACS Analysis
Single cell suspensions (106 cells) were prepared from spleen or
lymph nodes, and stained with fluorochrome-conjugated antibod-
ies. All antibodies were purchased from BD Biosciences or
eBioscience unless otherwise indicated. Antibodies were directly
labeled with one of the following fluorescent tags: FITC, PE,
Figure 1. Nicotinic acetylcholine receptor (nAChR) expression on NK cells. Spleen, or lymph node cell suspensions were obtained RAG22/2
mice, and FACS was performed as described in the Materials and Methods section. A. Representative dot plots of cell populations before and after
sorting are shown in the left- and right-hand panels, respectively. The purity of NK cells reached .98% purity after sorting. B. mRNA was purified
from the sorted NK cells, and cDNA was synthesized by reverse transcription. PCR was then performed using primers specific for each mouse nAChR
subunit. A positive control (+), using whole mouse brain cDNA, and a negative control (-), without cDNA, were included in each reaction. For each
nAChR subunit, bands from the positive control and at least one sample from each cell type were sequenced and confirmed as the correct PCR
product. C. nAChR expression assessed by radioligand saturation binding. Data depicted are representative from 2 to 3 separate experiments with
similar results.
doi:10.1371/journal.pone.0057495.g001
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PerCP, allophycocyanin (APC), PC5, or PC7. The following anti-
mouse antibodies were employed: CD3 (145-2C11), NKG2A
(20d5), NKG2D (CX5), Ly49 I (YLI-90), NK1.1 (PK136), perforin
(eBioOMAK-D) and granzyme B (16G6). Flow cytometric data
were collected on a FACSAriaTM flow cytometer (Becton
Dickinson, Mountain View, MD) and analyzed with DivaTM
software. Isotype-matched negative control mAbs were used for all
stains. To determine the percentage of cells producing selected
cytokines, values obtained with isotype controls were subtracted
from those with specific mAb.
Tumor in vivo Imaging
Bioluminescence images were obtained using an IVIS Imaging
System 200 Series (Caliper Life Sciences, Hopkinton, MA). For in
vitro imaging, bioluminescent cells were serially diluted from 105
cells in complete media into black, clear bottomed, 24-well plates
(Costar, Acton, MA, USA). D-luciferin (Caliper Life Sciences,
Hopkinton, MA.) at 150 mg/ml in media was added to each well
5–10 min before imaging. Imaging time was 1 min/plate. For in
vivo imaging, Mice received an intraperitoneal injection of D-
Luciferin 150-mg/kg (Caliper Life Sciences, Hopkinton, MA).
Mice were then placed onto the warmed stage inside the light-tight
camera box with continuous exposure to 1–2% isoflurane.
Imaging times ranged from 1 s to 3 mints. Regions of interest
from displayed images were identified around the tumor sites and
were quantified as total photon counts or photons/s using Living
ImageH software (Caliper Life Sciences, Hopkinton, MA).
Tumor challenge experiments were conducted with melanoma
B16 cells expressing luciferase. For quantitating tumor burden, at
10 minutes after the intraperitoneal injection of 3 mg/mouse D-
luciferin (Caliper Life Sciences, Hopkinton, MA), mice were
anesthetized and placed into the light tight chamber of an IVIS
200 bioluminescence imaging system (Caliper Life Sciences,
Hopkinton, MA). Data was collected as photons/sec/cm2 using
the Living ImageH software (Caliper Life Sciences, Hopkinton,
MA).
MRI was performed using a 7T small animal, 30-cm horizontal-
bore magnet and BioSpec Avance III spectrometer (Bruker,
Billerica, MA) with a 116 mm high power gradient set (600 mT/
m) and a 72 mm whole-body mouse transmit/surface receive coil
configuration. Axial and coronal T1-weighted (MSME; TE
10.5 ms, TR 322 ms, 0.5 mm slice thickness, matrix 2566256,
field of view (FOV) 2.8 cm, eight averages, 40 coronal slices, scan
time 22 minutes, and 20 axial slices, scan time 16 min) and fat-
suppressed turbo spin echo T2-weighted (RARE; TE1 14.5 ms,
TE2 65.5 ms, TR 4500 ms, 0.5 mm slice thickness, Matrix
2566256, FOV 2.8 cm, eight averages, 40 coronal slices, scan
time 28 minutes, and 20 axial slices, scan time 28 minutes) images
were acquired, covering the volume of brain from the olfactory
bulb/frontal lobe fissure to the cervical spinal cord. MRI data
were analyzed using the MEDx3.4.3 software package (Medical
Numerics, Virginia, USA) on a LINUX workstation.
Cytokine Quantification
Standard ELISAs for assessment of cytokine release by NK cells
(IFN-c, MIP1a, and GM-CSF) were performed using BD OptEIA
ELISA kit (BD Biosciences Pharmingen, San Diego, CA) as
previously described [18]. Results were expressed as mean
cytokine concentration (pg/ml) 6 SEM.
For intracellular cytokine staining, single cell suspensions were
prepared and incubated at 37uC for four days in round-bottomed
plates (26106 cells/well), and stimulated with a mixture of PMA
Figure 2. Nicotine alters NK cell phenotype via nAChR b2.Wild type (b2+/+) or nAChR b2 knock-out (b22/2) mice received nicotine (Nic) or PBS
for 21 days before they were scarified. Single cell suspensions were prepared from spleens. Frequency and phenotypes of NK cells within the
mononuclear cells were analyzed by FACS. A. Expression of NKG2D, NKG2A and Ly49I on gated NK1.1+CD32 cells. B. Expression of perforin and
granzyme B secreted by gated NK1.1+CD32 cells. The plot data represents results from two separate experiments (n = 3–4 mice/group). P values,
Student’s t-test, *p,0.05.
doi:10.1371/journal.pone.0057495.g002
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(20 ng/ml), ionomycin (1 mg/ml), and brefeldin A (5 mg/ml) for
another 5 h at 37uC. After harvesting, cells were stained for
surface markers, fixed and permeabilized with Cytofix/Cytoperm
kit (BD Biosciences), then stained with anti-IFN-c mAb (XMG1.2)
conjugated with Alexa 647. All samples were analyzed on a
FACSAriaTM using DivaTM software.
qRT-PCR
Total RNA was extracted from cell suspensions of spinal cords
using TRIzol (Invitrogen). First-strand cDNA of each sample was
synthesized using a reverse transcription kit (Invitrogen). RT-PCR
was performed as previously described, using an ABI Prism 7900-
HT sequence system (Applied Biosystems) with the QuantiTect
SYBR Green PCR kit (QIAGEN), in accordance with the
manufacturer’s instructions. The following primers were used:
NF-kB forward, 59-ATTTGAAACACTGGAAGCACGG-39; NF-
kB reverse, 59- CCGCCTTCTGCTTGTAGATAGG -39; IKKa
forward, 59-TGCACACCGTGCAGAGTCA -39; IKKa reverse,
59- TGCTTGCAGCCCAACAACT -39; hypoxanthine-guanine
phosphoribosyltransferase (HPRT) forward, 59-AGCCTAAGAT-
GAGCGCAAGT-39; and HPRT reverse, 59-TTACTAGGCA-
GATGGCCACA-39. The HPRT gene was amplified and served
as an endogenous control. 1 ml of first-strand cDNA product was
amplified with platinum Taq polymerase (Invitrogen) and gene-
specific primer pairs. Each sample was assayed in triplicate and
experiments were repeated twice. The relative amounts of mRNA
were calculated by plotting the Ct (cycle number), and mean
relative expression was determined by the 22DDCt comparative
method.
Figure 3. Nicotine impairs NK cell proliferation and killing of target cells by acting on nAChR b2. NK cells were sorted from splenocyte
single cell suspensions of wild type (b2+/+) or nAChR b2 knock-out (b22/2). A. Cells were then cultured in the presence of various concentrations of
nicotine (0.1, 1, 10 or 100 mM), and [3H]thymidine incorporation was measured (103 cpm + SEM; ordinate). B. NK cell numbers were assessed from b2+/
+ or b22/2 mice in the presence or absence of nicotine. (N = 6–8 per group; Student’s t-test, * p,0.05). C. 51Cr-labbed target cell YAC-1 were
incubated with NK cells derived from b2+/+ or b22/2 mice in the presence or absence of nicotine, at the indicated effector/target cell ratio. Killing of
target cells are measured by 51Cr release assay. D. B16 cells were incubated with NK cells derived from b2+/+ or b22/2 mice in the presence or
absence of nicotine. D-Luciferin was added to each well and the plate was imaged to obtain photons/s per cell. Wells with cells alone (no nicotine) or
cells (added nicotine) were included as controls. The killing of B16 cells are measured via bioluminescence imaging. The data of one experiment out
of two performed is shown, n = 3–4 mice/group. P values, Student’s t-test, *p,0.05. E. Production of IFN-c was measured by intracellular cytokine
staining. Dot plots are representative of two separate experiments (n = 6–18 mice). F. Production of IFN-c, TNF-a, GM-CSF, MIP-1a and MIP-b by
sorted NK cells was measured by ELISA. P values, Student’s t-test, *p,0.05.
doi:10.1371/journal.pone.0057495.g003
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Results
nAChR Expression Profile on NK Cells and Confirmation
by Ligand Binding Assays
To determine nAChR mRNA expression on NK cells, we
sorted NK cells from pooled splenocytes of RAG22/2 C57BL/6
mice that are devoid of T cells, NKT cells and B cells. mRNA was
extracted from highly purified NK cells (Figure 1A) and nAChR
expression profile was determined by PCR. Our results indicate
that NK cells express nAChR a4, a5, a6, b2 and b3 but not a3,
a7, a9; nor b4. Furthermore expression of b2 was particularly
strong (Figure 1B). We then investigated whether nAChR proteins
capable of engaging in nicotinic radioligand binding are assembled
in NK cells by using an 125I-labeled epibatidine (I-Epi) binding
assay (200 pM I-Epi +/2 100 mM carbamylcholine), as described
elsewhere [14,19,20,21]. NK cells (,1 million) were purified by
FACS, and mouse brain cortex homogenate was used as a positive
control. Specific I-Epi binding was 99 fmol/mg protein in NK
cells, about equal to specific binding levels in mouse whole brain
(Figure 1C). These data demonstrate that NK cells express
significant numbers of assembled nAChRs (as well as nAChR
subunit mRNAs as shown previously) at levels that can be
quantified with this assay. Since I-Epi binds to both b2- and b4-
containing nAChRs [14], competitive binding with the nAChR
b2-selective compound A85380 was used to discriminate between
these two receptor subtypes. We found that A85380 largely
abrogated I-Epi binding, demonstrating that the vast majority of
nAChRs present on NK cells contain the b2 subunit (Figure 1C).
Collectively, our results reveal that NK cells express an array of
nAChR mRNAs and that most of these subunits assemble into b2-
containing nAChRs. The strong expression of nAChR b2 in NK
cells, both at the mRNA and protein levels suggest that b2-
containing nAChRs are candidates for mediation of nicotine’s
effects on NK cell activity.
Influence of nAChR b2 Deficiency on Expression of NK
Cell Receptors and Effector Molecules
NK cell functions are dictated by stimulatory and inhibitory
receptors on NK cells. Activating signals are generated through
NK group 2 member (NKG2D), which recognize the stress-
inducible molecules MHC class I chain-related proteins (MICA
and MICB) and the UL-16-binding proteins 1-4 (ULBP1-4), also
known as RAET proteins, or through natural cytotoxicity
receptors (NCRs) that recognize viral hemagglutinin and as yet
undefined tumor-associated ligand. The inhibitory signals are
generated by binding of MHC class I molecules to killer cell
immunoglobulin-like receptors (KIRs) in humans, or to Ly49 in
mice, in addition to the CD94/NKG2A heterodimer in both
species [22,23]. We compared the expression of several of these
receptors on spleen NK cells isolated from nicotine- or PBS-
exposed mice and investigated the influence, if any, of nAChR b2
deficiency. Expression of inhibitory receptor NKG2A is not
significantly altered on NK cells by nicotine; whereas expression of
NKG2D and Ly49I were reduced in mice that received nicotine,
and such reductions are largely abrogated in nAChR b22/2 mice
(Figure 2A) [13]. Similar findings were obtained regarding
expression of NK cell effector molecular Granzyme B and perforin
(Figure 2B). We also observed that nicotine has a similar effect on
lung-derived NK cells receptor profile and effector molecules (data
not shown).
nAChR b2 Deficiency Reverses the Inhibitory Effects of
Nicotine on NK Cell Functions
To understand the biological consequences of altered NK cell
receptor expression induced by nicotine exposure, we investigated
the effects of nicotine on NK cell mediated killing of target cells, as
well as release of cytokines by NK cells. NK cells normal represent
5–10% of peripheral blood mononuclear cells in human and 1–
3% of monocytes in mouse spleen or lymph node. For NK cells to
perform their functions, these cells must proliferate under
pathological situations. Thus, we first assessed the influence of
nicotine on NK cell proliferation and found that nicotine reduced
NK cell proliferation and numbers (Figure 3A, B). nAChR b2
deficiency largely restored the capacity of NK cells to proliferate
and numbers in the presence of nicotine (Figure 3A, B).
Next, we assessed the influence of nicotine on NK cell lytic
activity and potential roles for nAChR b2. Compared with control
mice that received PBS, NK cells from nicotine-treated mice
exhibited reduced cytotoxicity against YAC-1, a classic NK target
cell with lower MHC class I expression (Figure 3C). Primary
Figure 4. Nicotine inhibits NF-kB activation in NK cells through nAChR b2. NK cells were sorted from splenocyte single cell suspensions of
RAG22/2 and RAG22/2b22/2mice. NF-kB and IKKamRNA of sorted NK cells in b2+/+ or b22/2mice received nicotine (Nic) was measured by qRT-PCR.
The data of one experiment out of two performed is shown, n = 3–4 mice/group. P values, Student’s t-test, *p,0.05.
doi:10.1371/journal.pone.0057495.g004
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human and mouse melanoma, or cell lines, shared expression of
ligands for natural cytotoxicity receptors (NCRs) and DNAX
accessory molecule-1 (DNAM-1), the two emerging NK cell
receptors key for cancer recognition [15]. Further, these cells have
low MHC class I expression [15]. NK cells are thus able to
recognize and lyse human and mouse melanoma cells in vitro and
in vivo, and to prevent melanoma metastasis in adoptive transfer
experiments [24]. We therefore used the murine B16 cell line,
derived from spontaneous murine melanoma, and demonstrated
that NK cells readily kill B16 tumor cells, and that this effect was
significantly reduced when exposed to nicotine (Figure 3C, D). To
investigate the contributions of nAChR b2 receptor to mediate the
effects of nicotine, we perform these experiments using nAChR
b22/2 NK cells (Figure 3C, D). In all experiments, nAChR b2
deficiency significantly abrogated the effects of nicotine.
Last, we examine the impact of nicotine on cytokine production
by NK cells. Compared with control mice, IFN-c, GM-CSF, MIP-
1a, MIP-1b and TNF-a secretion were reduced in mice received
nicotine (Figure 3E, F). Again, these parameters were reversed to a
great extent in nAChR b22/2 mice . Collectively, our results
demonstrate that nicotine impairs NK cell functions including
proliferation, cytotoxicity toward YAC-1 cell and B16 tumor cells,
and production of cytokines. Our findings also show that despite
expression of multiple nAChRs, nAChR b2 emerged as a key
mediator for nicotinic effects on NK cells, as deficiency of nAChR
a7 fails to significantly alter the influence of nicotine on NK cells
(data not shown).
Nicotine Inhibits NF-kB Transactivation in NK Cells
through nAChR b2
Mobilization of the transcription factor NF-kB is an essential
step for NK cell activation and proceeds its cytotoxicic activity and
production of cytokines. To evaluate the impact of nicotine on NF-
kB activity in NK cells, we sorted NK cells from the spleen of
RAG22/2 mice, and cultured the isolated NK cells alone or with
nicotine for 24 h. We performed a series of real-time PCR
experiments looking at changes in transcript abundance, and saw
Figure 5. Impairment of NK cell-dependent suppression of B16 tumor cell metastasis by nicotine is mediated by nAChR b2. Mice of
different genotypes received nicotine (Nic) or PBS for 21 days and engrafted with the B16 melanoma cell line (16106 cells/mouse). A. Seven or 14
days later, a portion of mice were euthanized and the lung dissected. Total numbers of melanoma nodules counted in these organs are shown (n= 12
mice/group). B, C. Quantification of tumor growth in these animals during the period are achieved via bioluminescence imaging (B) and high field
MRI (C for T1 images; Figure S2 denotes Th2 images. N= 15–18/group. P values, ANOVA, *p,0.05. D. Survival for the remaining animals are
monitored for 60 days (n = 15–18 mice/group). E. Mice were engrafted with melanoma cells lines (16106/mouse) in the presence or absence of
nicotine, and NK cells (56105 NK cells/mouse) from wild type or nAChR b22/2 mice. Mice were then monitored for survival up to 60 days. Results are
pooled from three experiments with similar results. N = 6–8 mice/group.
doi:10.1371/journal.pone.0057495.g005
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that addition of nicotine suppressed gene transcription of NF-kB,
and IKKa, an alternative regulator of NF-kB in NK cells
(Figure 4). To determine if nAChR b2 is involved, we cross-bred
RAG22/2 with nAChR b22/2 mice to generate double knockout
mice. When NK cells derived from these mice were used, the effect
of nicotine on NF-kB and IKKa transcription becomes
minimum(Figure 4). Thus, nAChR b2 mediates the effects of
nicotine on NK cell transcription genes that are critical for their
functions.
Nicotine Exposure Promotes Lung Metastasis, a Process
Dependent on nAChR b2
Cigarette smoke has been experimentally demonstrated to
increase lung metastatic tumor burden [11]. As multiple chemicals
contained in cigarette smoke can have this effect, we sought to
specifically address the role of nicotine exposure in this process. To
this end, we adopted the murine B16 cell line derived from
spontaneous murine melanoma. Because B16 tumor cells have
high lung metastasis potential and such metastasis can be inhibited
by NK cells, this model is ideal to address the role of nicotine and
its receptors in this pathological process. For this purpose, C57BL/
6 RAG22/2 mice were treated with nicotine or PBS via osmotic
pump implantation for 14 days and beyond. The dosage selection
is based on smokers and justified in detail in the methods section
and in our previous publications [7,8]. These mice were then
challenged i.v. with 16106 B16- melanoma cells. Based on the
literature [11,15,16], we did preparation experiments in which
tumor burden and survival rates were compared in mice receiving
16105, 2.56105, 56105, 16106 and 2.56106 B16 cells. We found
that transplantation of 16106 provided the most efficient
comparison of tumor burden, and thus this concentration was
used for all subsequent experiments (Table S1). 14 days of nicotine
or PBS exposure at the onset of tumor challenge lead to no
significant difference in tumor burden between the two groups
(data not shown). Nicotine was thus continuously released in these
mice until 21 days post tumor challenge. Compared with control
mice that received PBS, mice treated with nicotine had
significantly greater lung tumor burden (Figure S1; Figure 5A),
increased bioluminescence imaging (Figure 5B),tumor volume
when assessed by high field MRI of both T1 (Figure 5C) and T2
imaging (Figure S2), as well as decreased survival rates (Figure 5D).
To determine the contributions of nicotinic receptors, we cross-
breed RAG22/2 with mice lacking nAChR a7 or b2, two
nAChRs prominently expressed by NK cells, and performed
similar experiments as described above. Lack of a7 receptors
exerted little influence on B16 cell lung metastasis promoted by
nicotine (data not shown). In contrast, promotion of metastasis by
nicotine is largely diminished in RAG22/2b22/2 mice, as the
tumor burden was indistinguishable between RAG22/2 and
RAG22/2b22/2 mice (Figure 5A–C). Thus, b2 receptor plays a
critical role in mediating the effects of nicotine’s facilitation of lung
tumor metastasis.
nAChR b2 Determines NK Cell-dependent Tumor
Metastasis
The effects of nicotine in promoting B16 cell line lung metastasis
can be achieved via a direct effect on tumor cells, lung
microenvironment, or immune cells. We focused our investiga-
tions on NK cells because of their known effects in constraining
B16 cell metastasis, as well as strong expression of several nAChRs
in these cells. In addition, as RAG22/2 mice have no intrinsic T
and B cells, the role for nAChR b2 in determining the effect of
nicotine in tumor metastasis is likely via NK cells. We therefore
first compared tumor burden and survival rates in RAG22/2 and
RAG2cc2/2 mice. Clearly, the lungs of RAG22/2cc2/2 mice
had larger tumor burden and majority of these mice quickly
succumb to death after B16 cell challenge (Figure S1; Figure 5E).
Our results thus confirm the role of endogenous NK cells in
restricting B16 lung metastasis.
Next, we determined the role of nAChR b2 on NK cells in
curbing tumor metastasis. For this purpose, we co-transfered B16
tumor cells with NK cells isolated from wild type and nAChR
b22/2 mice, into the recipient RAG22/2cc2/2 mice. Lung
tumor number and survival rates were indistinguishable between
B16-recipient RAG22/2cc2/2 treated with or without nicotine
(Figure 5E). Thus significant roles for macrophage, dendritic cells
and other cells in B16 lung metastasis are largely ruled out.
Further, co-transfer of NK cells isolated from PBS-treated control
mice improve the survival rate of recipient mice. However, such
improvement is reduced markedly when NK cells derived from
nicotine-treated mice are used for transfer experiments. Impor-
tantely, when transfer of NK cells isolated from b22/2 mice,
irrespective nicotine treatment, improved the survival rate
(Figure 5E), whereas nicotine maintains its impact on B16 tumor
cell metastasis when a72/2 NK cells are co-transferred (data not
shown) Therefore, our results suggest that nAChR b2 determines
NK cell-dependent tumor metastasis.
Discussion
Despite ongoing efforts to reduce smoking prevalence, over 1.1
billion people continue to smoke, and smokers in countries like
China comprise a large portion of the overall smoking population,
which is estimated about one-sixth of the world’s population [2].
Due to the prominent association of smoking with lung tumor and
lung metastasis, we addressed several critical issues regarding
cigarette smoke, immunity and tumor metastasis in a well
established murine lung metastasis model following B16 melano-
ma challenge. The combined effects of enormous carcinogens, as
well as multiple immune suppressive chemicals contained in
cigarette smoke contribute to tumorigenesis. Until now, how
nicotine, the psychoactive component of tobacco products, affects
NK cells and their ability to perform immune surveillance against
lung tumors, and which nAChRs mediate such events, were not
known.
Several findings revealed by the current study are significant.
First, we defined the influence of nicotine on the phenotype and
functions of NK cells. Overall, we found that nicotine exposure
reduces expression of NK cell-related activating signals as well as
NK cell-associated immune effector molecules. This was associ-
ated with reduced NK cell proliferation, production of cytokines,
cytolytic activity against target cells, and transactivation of NF-kB.
Second, we are able to identify that among several nAChRs, the
b2 subunit emerged as a principle mediator for these inhibitory
effects of nicotine on NK cells. Third, we demonstrated the impact
of nicotine on NK cells, as well as the involvement of nAChR b2,
on the ability of these cells to perform immunosurveillance against
murine B16 melanoma, a counterpart to a a highly prevalent and
malignant cancer in humans.
Effective immune responses against lung tumor growth and
metastasis rely on a strong activation of NK cells, CTLs as well as
type 1 immunity. Weak antigenic stimuli by tumor antigens
coupled with active suppression by regulatory cells preclude the
difficulty in achieving effective anti-tumor immunity in vivo. Tumor
intrinsic factors including reduced expression of class I molecule
triggers NK cell cytotoxic activity. Tumor over growth, tissue
damage and inflammation mobilize the cytokine synthesis
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machinery in NK cells. Early and burst release of IFN-c in turn
boosts type 1 immunity and CTLs and amplifies anti-tumor
immunity. Suppression of both cytotocixic activity and cytokine
production by NK cells essentially blunt two arms of NK cell –
mediated anti-tumor immunity. Indeed, we found an significant
increase in lung tumor burden in mice that received nicotine, and
such an increase can be linked to compromised NK cell functions.
In terms of melanoma, recognition of tumor cells by NK cells
appears important to prevent metastasis. Expression of NK
receptors NCR and DNAM-1 by both human and murine
melanoma cells, as well as reduced expression of MHC-class I
molecule, lead to recognition by NK cells and trigger the loss of
NK cell tolerance. The importance of NCR is highlighted by
evidence that NCR-expressing NK cell clones were required for
the elimination of lung carcinoma and, conversely, loss of NRC
expression on lung-resident NK cells led to tumor progression
[15]. Whether nicotine directly affects expression of NCR or the
accessory molecule DNAM-1 awaits further investigation. The
lung metastasis model recapitulates the homogenous spread of
melanoma. In adoptive transfer models, NK cells are sufficient to
reduce tumor burden in the lung as well as other organs (data not
shown).
Mammalian nAChR subunits are derived from a family of
sixteen different genes (a1–a7, a9–a10, b1–b4, c, d and e) and
each have distinct distributions. The combinations and order of
nAChR subunits within functional pentamers dictate nAChR
subtype properties [25,26]. Despite that nAChR expression has
been examined in macrophages, dendritic cells, monocytes, T cells
and B cells [27], expression prolife of nAChRs and their functions
on NK cells have not been previously reported. Here we
demonstrated that NK cells express nAChR a4, a5, a6, b2 and
b3. In addition, positive ligand binding assay results imply nAChR
b2 expression on NK cells may have biological functions. Indeed,
influence of nicotine on NK cells, both at cellular and molecular
levels, was largely abrogated in nAChR b2 deficient mice. The in
vivo effects of nicotine in augmenting B16 metastasis become
minimum in nAChR b2/RAG1 double knock-out mice, implying
a crucial role for nAChR b2 in NK cells, which can not be
compensated by other nAChRs. The role for a7 expression on
macrophages in the peripheral immune system and microglia
within the central nervous system in mediating the cholinergic
anti-inflammatory effects are highlighted by recent studies [7,8].
Despite the prominent role for nAChR a7, expression of other
nAChRs appears to also influence the functions of macrophages
and microglia [3,4]. However, we found that only nAChR b2
appears as a prominent mediator for nicotine’s effects on NK cells.
The overlapping expression pattern and their functional discrep-
ancy of nAChR on macrophage and NK cells are interesting and
deserve in depth investigation.
Taken together, our studies have revealed that NK cells express
nAChR b2 which determine their function in controlling lung
tumor metastasis in a murine model. These data reveal new insight
in smoking-induced pathologies. Restoration of altered NK cell
function induced by nicotine and smoking may possibly boost their
capacity to prevent dissemination of early stage melanoma.
Supporting Information
Figure S1 Gross appearance of B16 tumor cell metas-
tasis to lung in mice received PBS or nicotine. Mice of
different genotypes received nicotine (Nic) or PBS for 21 days and
engrafted with B16 melanoma cells lines (16106 cells/mouse).
Seven of 14 days later, a portion of mice were euthanized and the
lung dissected. Representative pictures of lungs are shown.
(TIF)
Figure S2 B16 melanoma cells dissemination in lung
visualized by MRI T2 images. Mice of different genotypes
received nicotine (Nic) or PBS for 21 days and engrafted with B16
melanoma cells lines (16106 cells/mouse). T2 7MRI image denote
B16 melanoma tumor cell dissemination in lung.
(TIF)
Table S1 Comparison of numbers of lung metastasis in
mice engrafted with different numbers of tumor cells.
Mice of different genotypes received nicotine (Nic) or PBS for 21
days and engrafted with B16 different numbers of melanoma cells
lines as indicated. 14 of 21 days later, mice were euthanized and
the lung dissected. Total numbers of melanoma nodules counted
in these lungs are compared (n= 6 mice/group).
(DOC)
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